Maravai LifeSciences Holdings Inc
(NAS:MRVI)
$
5.92
0.3 (5.34%)
Market Cap: 839.71 Mil
Enterprise Value: 780.08 Mil
PE Ratio: 0
PB Ratio: 2.43
GF Score: 74/100 Maravai LifeSciences Holdings Inc at UBS Global Healthcare Conference Transcript
May 25, 2022 / 02:45PM GMT
Release Date Price:
$34.21
(+0.29%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Hi, I'm John Sourbeer. I cover life sciences, diagnostic tools and pharma services at UBS. Excited for our next fireside chat. We have Maravai. And with us is Kevin Herde, CFO. Great. Welcome, Kevin.
Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO
Thanks, John.
Questions & Answers
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate
Great. So -- and also a reminder, if anyone in the audience has any questions, you can send it through and we have the iPads up here, and we can take them as well. So I guess to start off on COVID, you provided CleanCap guidance this year, 12% to 14% growth. Any update on where this stands on what is contracted and kind of what is driving the guidance for the year?
Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO
Yes, certainly, John. I mean I think the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot